"Orange County Research Institute is a clinical research center that has been serving the community since 2011. We participated and partnered with pharmaceutical companies that led to ground breaking research trials that have paved the way to new , safe and efficacious drugs that have introduced and improved treatment of various conditions such as Diabetes, Hypertension, Hypercholesterolemia, Chronic Low Back Pain, Osteoarthritis, Fibromyalgia, Neuropathy , Insomnia, Alzheimer’s Disease and various other medical conditions. Our team is led by Dr. Steve Sitar who specializes in Internal Medicine and has served patients in Orange County for 28 years. He is affiliated with Anaheim Regional Medical Center."

During the past decade, Orange County Research Institute conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 12 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Orange County Research Institute" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Pfizer" with 5 trials sponsored, "Mallinckrodt" with 2 trials sponsored, "Purdue Pharma LP" with 2 trials sponsored and "Acumen Pharmaceuticals" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orange County Research Institute" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator, "Accelovance" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "DF/Net Research" with 1 trials as a collaborator and "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Orange County Research Institute" are "Atopic Dermatitis" (3 trials), "Osteoarthritis, Knee" (3 trials), "Chronic Low Back Pain" (2 trials), "Low Back Pain" (2 trials) and "Migraine" (2 trials). Many other conditions were trialed in "Orange County Research Institute" in a lesser frequency.

Most popular intervention types in "Orange County Research Institute" are "Drug" (21 trials), "Biological" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Lebrikizumab" (3 trials), "Galcanezumab" (2 trials), "Lasmiditan" (2 trials) and "Multivalent" (2 trials). Other intervention names were less common.

The vast majority of trials in "Orange County Research Institute" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Orange County Research Institute". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Orange County Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Orange County Research Institute, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".